These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 22061863)

  • 1. A novel splicing mutation in FKBP10 causing osteogenesis imperfecta with a possible mineralization defect.
    Venturi G; Monti E; Dalle Carbonare L; Corradi M; Gandini A; Valenti MT; Boner A; Antoniazzi F
    Bone; 2012 Jan; 50(1):343-9. PubMed ID: 22061863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family.
    Xia XY; Cui YX; Huang YF; Pan LJ; Yang B; Wang HY; Li XJ; Shi YC; Lu HY; Zhou YC
    Clin Chim Acta; 2008 Dec; 398(1-2):148-51. PubMed ID: 18755172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in FKBP10 cause recessive osteogenesis imperfecta and Bruck syndrome.
    Kelley BP; Malfait F; Bonafe L; Baldridge D; Homan E; Symoens S; Willaert A; Elcioglu N; Van Maldergem L; Verellen-Dumoulin C; Gillerot Y; Napierala D; Krakow D; Beighton P; Superti-Furga A; De Paepe A; Lee B
    J Bone Miner Res; 2011 Mar; 26(3):666-72. PubMed ID: 20839288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing defect in FKBP10 gene causes autosomal recessive osteogenesis imperfecta disease: a case report.
    Maghami F; Tabei SMB; Moravej H; Dastsooz H; Modarresi F; Silawi M; Faghihi MA
    BMC Med Genet; 2018 May; 19(1):86. PubMed ID: 29801479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenesis imperfecta type VI: a form of brittle bone disease with a mineralization defect.
    Glorieux FH; Ward LM; Rauch F; Lalic L; Roughley PJ; Travers R
    J Bone Miner Res; 2002 Jan; 17(1):30-8. PubMed ID: 11771667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational spectrum of type I collagen genes in Korean patients with osteogenesis imperfecta.
    Lee KS; Song HR; Cho TJ; Kim HJ; Lee TM; Jin HS; Park HY; Kang S; Jung SC; Koo SK
    Hum Mutat; 2006 Jun; 27(6):599. PubMed ID: 16705691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of FKBP10 in recessive type XI osteogenesis imperfecta leads to diminished collagen cross-linking and reduced collagen deposition in extracellular matrix.
    Barnes AM; Cabral WA; Weis M; Makareeva E; Mertz EL; Leikin S; Eyre D; Trujillo C; Marini JC
    Hum Mutat; 2012 Nov; 33(11):1589-98. PubMed ID: 22718341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel homozygous 5 bp deletion in FKBP10 causes clinically Bruck syndrome in an Indonesian patient.
    Setijowati ED; van Dijk FS; Cobben JM; van Rijn RR; Sistermans EA; Faradz SM; Kawiyana S; Pals G
    Eur J Med Genet; 2012 Jan; 55(1):17-21. PubMed ID: 22085994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic basis for skeletal disease. Osteogenesis imperfecta and genetic abnormalities].
    Hasegawa K
    Clin Calcium; 2010 Aug; 20(8):1190-5. PubMed ID: 20675929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of expression of SERPINF1, the gene coding for pigment epithelium-derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen.
    Venturi G; Gandini A; Monti E; Dalle Carbonare L; Corradi M; Vincenzi M; Valenti MT; Valli M; Pelilli E; Boner A; Mottes M; Antoniazzi F
    J Bone Miner Res; 2012 Mar; 27(3):723-8. PubMed ID: 22113968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the gene encoding the RER protein FKBP65 cause autosomal-recessive osteogenesis imperfecta.
    Alanay Y; Avaygan H; Camacho N; Utine GE; Boduroglu K; Aktas D; Alikasifoglu M; Tuncbilek E; Orhan D; Bakar FT; Zabel B; Superti-Furga A; Bruckner-Tuderman L; Curry CJ; Pyott S; Byers PH; Eyre DR; Baldridge D; Lee B; Merrill AE; Davis EC; Cohn DH; Akarsu N; Krakow D
    Am J Hum Genet; 2010 Apr; 86(4):551-9. PubMed ID: 20362275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel mutations in FKBP10 in Chinese patients with osteogenesis imperfecta and their treatment with zoledronic acid.
    Xu XJ; Lv F; Liu Y; Wang JY; Ma DD; Asan ; Wang JW; Song LJ; Jiang Y; Wang O; Xia WB; Xing XP; Li M
    J Hum Genet; 2017 Feb; 62(2):205-211. PubMed ID: 27762305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical features and molecular characterization of Chinese patients with FKBP10 variants.
    Tan Z; Shek HT; Chen P; Dong Z; Zhou Y; Yin S; Qiu A; Dong L; Gao B; To MKT
    Mol Genet Genomic Med; 2023 Apr; 11(4):e2122. PubMed ID: 36655627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in FKBP10, which result in Bruck syndrome and recessive forms of osteogenesis imperfecta, inhibit the hydroxylation of telopeptide lysines in bone collagen.
    Schwarze U; Cundy T; Pyott SM; Christiansen HE; Hegde MR; Bank RA; Pals G; Ankala A; Conneely K; Seaver L; Yandow SM; Raney E; Babovic-Vuksanovic D; Stoler J; Ben-Neriah Z; Segel R; Lieberman S; Siderius L; Al-Aqeel A; Hannibal M; Hudgins L; McPherson E; Clemens M; Sussman MD; Steiner RD; Mahan J; Smith R; Anyane-Yeboa K; Wynn J; Chong K; Uster T; Aftimos S; Sutton VR; Davis EC; Kim LS; Weis MA; Eyre D; Byers PH
    Hum Mol Genet; 2013 Jan; 22(1):1-17. PubMed ID: 22949511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COL1A1 mutation analysis in Lithuanian patients with osteogenesis imperfecta.
    Benusiené E; Kucinskas V
    J Appl Genet; 2003; 44(1):95-102. PubMed ID: 12590186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and biochemical analyses of Israeli osteogenesis imperfecta patients.
    Ries-Levavi L; Ish-Shalom T; Frydman M; Lev D; Cohen S; Barkai G; Goldman B; Byers P; Friedman E
    Hum Mutat; 2004 Apr; 23(4):399-400. PubMed ID: 15024745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction of a mineralization defect by overexpression of a wild-type cDNA for COL1A1 in marrow stromal cells (MSCs) from a patient with osteogenesis imperfecta: a strategy for rescuing mutations that produce dominant-negative protein defects.
    Pochampally RR; Horwitz EM; DiGirolamo CM; Stokes DS; Prockop DJ
    Gene Ther; 2005 Jul; 12(14):1119-25. PubMed ID: 15815702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteogenesis imperfecta: clinical, biochemical and molecular findings.
    Venturi G; Tedeschi E; Mottes M; Valli M; Camilot M; Viglio S; Antoniazzi F; Tatò L
    Clin Genet; 2006 Aug; 70(2):131-9. PubMed ID: 16879195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel FKBP10 Mutation in a Patient with Osteogenesis Imperfecta Type XI.
    Seyedhassani SM; Hashemi-Gorji F; Yavari M; Harazi F; Yassaee VR
    Fetal Pediatr Pathol; 2016; 35(5):353-358. PubMed ID: 27362741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.
    Hartikka H; Kuurila K; Körkkö J; Kaitila I; Grénman R; Pynnönen S; Hyland JC; Ala-Kokko L
    Hum Mutat; 2004 Aug; 24(2):147-54. PubMed ID: 15241796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.